Core Laboratories (CLB) Expected to Release Earnings on Wednesday

Core Laboratories (NYSE:CLB) is projected to announce its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect Core Laboratories to announce earnings of $0.08 per share and revenue of $126.2580 million for the quarter. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Parties can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, July 30, 2026 at 8:30 AM ET.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, hitting the consensus estimate of $0.06. The business had revenue of $121.80 million for the quarter, compared to analyst estimates of $122.99 million. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. Core Laboratories’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.14 EPS. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Stock Up 0.1%

Shares of NYSE CLB opened at $11.68 on Monday. The stock has a market cap of $538.54 million, a P/E ratio of 17.97, a P/E/G ratio of 2.82 and a beta of 1.00. The firm has a 50 day moving average price of $12.35 and a 200 day moving average price of $15.49. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. Core Laboratories has a 52-week low of $9.72 and a 52-week high of $20.36.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Monday, May 11th were issued a $0.01 dividend. The ex-dividend date was Monday, May 11th. This represents a $0.04 annualized dividend and a yield of 0.3%. Core Laboratories’s dividend payout ratio (DPR) is 6.15%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CLB. Wall Street Zen lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. Weiss Ratings downgraded Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Core Laboratories currently has an average rating of “Reduce”.

Institutional Trading of Core Laboratories

Several hedge funds have recently bought and sold shares of CLB. Corient Private Wealth LLC bought a new position in Core Laboratories in the fourth quarter valued at approximately $219,000. T. Rowe Price Investment Management Inc. increased its position in shares of Core Laboratories by 14.8% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,042,208 shares of the oil and gas company’s stock worth $16,707,000 after acquiring an additional 134,050 shares in the last quarter. XTX Topco Ltd increased its position in shares of Core Laboratories by 110.9% during the fourth quarter. XTX Topco Ltd now owns 54,273 shares of the oil and gas company’s stock worth $870,000 after acquiring an additional 28,541 shares in the last quarter. Old West Investment Management LLC acquired a new stake in shares of Core Laboratories during the fourth quarter worth $613,000. Finally, AQR Capital Management LLC raised its holdings in shares of Core Laboratories by 32.6% during the fourth quarter. AQR Capital Management LLC now owns 49,818 shares of the oil and gas company’s stock worth $799,000 after acquiring an additional 12,242 shares during the period. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.